Key Dates

Related Announcements

PAR-22-205 - NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed

Issued by

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Purpose

This Notice informs potential applicants that funding opportunity announcement (FOA) PAR-22-205 "NIAMS Clinical Trial Planning Grant (R34) - Clinical Trial Not Allowed" has been amended to add an additional application due date. Changes under Part 1. Overview, Key Dates Section of the FOA are shown below:

Currently reads:

Key Dates
Open Date (Earliest Submission Date)       
February 03, 2023

Letter of Intent Due Date(s)                                  
February 03, 2023

Application Due Date(s)                              
March 3, 2023; July 2, 2023; November 3, 2023, by 5:00 PM local time of applicant organization.
Scientific Merit Review                                
July 2023; November 2023; March 2024

Advisory Council Review                              
October 2023; January 2024; May 2024

Earliest Start Date                                        
December 2023; April 2024; July 2024

Modified to read (changes shown in bold italics):

Key Dates
Open Date (Earliest Submission Date)
October 1, 2022

Letter of Intent Due Date(s)
October 1, 2022

Application Due Date(s)
November 1, 2022; March 3, 2023; July 2, 2023; November 3, 2023, by 5:00 PM local time of applicant organization.

Scientific Merit Review
February/March 2022; July 2023; November 2023; March 2024

Advisory Council Review
May 2023; October 2023; January 2024; May 2024

Earliest Start Date
July 2023; December 2023; April 2024; July 2024

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

NIAMS Clinical Research Team
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Email: [email protected]